Literature DB >> 7284334

Interaction of tubulin with drugs and alkylating agents. 2. Effects of colchicine, podophyllotoxin, and vinblastine on the alkylation of tubulin.

R F Ludueña, M C Roach.   

Abstract

The antimitotic drugs colchicine, podophyllotoxin, and vinblastine are known to be potent inhibitors of microtubule polymerization, but little is known about how they affect the chemical properties of the tubulin molecule. In the preceding paper [Ludueña, R. F., & Roach, M. C. (1981) Bio-chemistry (preceding paper in this issue)], we have shown that the alkylating agent iodo[14C]acetamide reacts specifically with the sulfhydryl groups of tubulin and that its bifunctional analogue, N,N'-ethylenebis(iodoacetamide) (EBI), reacts with native tubulin to convert beta-tubulin into a form, designated beta*, which appears to represent an intrachain cross-linked form of beta. In this paper, we have incubated tubulin with the drugs prior to alkylation and measured their effects on the alkylation reactions. We have found that at 100 microM concentrations, podophyllotoxin, colchicine, and vinblastine inhibited the reaction of tubulin with iodo[14C]acetamide by 19-32%, 33-47%, and 62-72%, respectively; each drug was half-maximally effective at 3-5 microM, indicating that the suppressive effects of the drugs were mediated by their high-affinity binding sites. Similarly, beta* formation induced by EBI was suppressed by 92-94% in the presence of either colchicine or podophyllotoxin In contrast, vinblastine enhanced beta* formation by 40%. Alkylation with longer chain analogues of EBI revealed no evidence that the reactive sulfhydryls were being pushed apart by the drugs. These results indicate that each of the drugs has potent effects on the accessibility of the sulfhydryl groups of tubulin and that the effects of vinblastine are very different from those of either colchicine or podophyllotoxin.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7284334     DOI: 10.1021/bi00518a032

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Novel suicide ligands of tubulin arrest cancer cells in S-phase.

Authors:  A Davis; J D Jiang; K M Middleton; Y Wang; I Weisz; Y H Ling; J G Bekesi
Journal:  Neoplasia       Date:  1999-12       Impact factor: 5.715

2.  Posttranslational modification of tubulin by palmitoylation: I. In vivo and cell-free studies.

Authors:  J M Caron
Journal:  Mol Biol Cell       Date:  1997-04       Impact factor: 4.138

3.  Localization of the colchicine-binding site of tubulin.

Authors:  S Uppuluri; L Knipling; D L Sackett; J Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

4.  Effect of two pyrimidine analogs on accumulation of tubulin in NHIK 3025 cells.

Authors:  M E Juul; J M Dornish; N O Juul; E O Pettersen; R Oftebro
Journal:  Mol Cell Biochem       Date:  1990-08-10       Impact factor: 3.396

5.  Use of N,N'-polymethylenebis(iodoacetamide) derivatives as probes for the detection of conformational differences in tubulin isotypes.

Authors:  J Sharma; R F Ludueña
Journal:  J Protein Chem       Date:  1994-02

6.  Quick and simple detection technique to assess the binding of antimicrotubule agents to the colchicine-binding site.

Authors:  Sébastien Fortin; Jacques Lacroix; Marie-France Côté; Emmanuel Moreau; Eric Petitclerc; René C-Gaudreault
Journal:  Biol Proced Online       Date:  2010-04-08       Impact factor: 3.244

7.  The Microtubule Inhibitor Podofilox Inhibits an Early Entry Step of Human Cytomegalovirus.

Authors:  Tobias Cohen; Toni M Schwarz; Frederic Vigant; Thomas J Gardner; Rosmel E Hernandez; Benhur Lee; Domenico Tortorella
Journal:  Viruses       Date:  2016-10-24       Impact factor: 5.048

8.  Structural differences between brain beta 1- and beta 2-tubulins: implications for microtubule assembly and colchicine binding.

Authors:  M Little; R F Ludueña
Journal:  EMBO J       Date:  1985-01       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.